MedPath

APOTEX PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

TGA:3

Drug Approvals

PALONOSETRON APOTEX palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial (246563)

Product Name
PALONOSETRON APOTEX palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial
Approval Date
May 13, 2016
TGA

GenRx PALONOSETRON palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial (246562)

Product Name
GenRx PALONOSETRON palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial
Approval Date
May 13, 2016
TGA

APO-PALONOSETRON palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial (246564)

Product Name
APO-PALONOSETRON palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial
Approval Date
May 13, 2016
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.